OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 91 filers reported holding OVID THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,208,000 | -34.9% | 955,690 | +61.8% | 0.01% | -42.9% |
| Q3 2020 | $3,391,000 | +0.4% | 590,761 | +28.9% | 0.01% | -6.7% |
| Q2 2020 | $3,377,000 | +1531.4% | 458,253 | +559.6% | 0.02% | +1400.0% |
| Q1 2020 | $207,000 | -83.6% | 69,471 | -68.7% | 0.00% | -87.5% |
| Q3 2018 | $1,260,000 | -34.8% | 222,139 | -10.3% | 0.01% | -46.7% |
| Q2 2018 | $1,932,000 | +10.3% | 247,733 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $1,751,000 | -46.8% | 247,733 | -25.7% | 0.02% | -48.3% |
| Q4 2017 | $3,290,000 | +15.2% | 333,333 | 0.0% | 0.03% | +26.1% |
| Q3 2017 | $2,857,000 | -18.3% | 333,333 | 0.0% | 0.02% | -25.8% |
| Q2 2017 | $3,497,000 | – | 333,333 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,483,059 | $9,982,000 | 5.39% |
| EcoR1 Capital, LLC | 6,082,200 | $24,450,000 | 1.08% |
| BVF INC/IL | 6,417,551 | $25,799,000 | 0.97% |
| Fairpointe Capital LLC | 71,700 | $288,000 | 0.44% |
| CHI Advisors LLC | 247,510 | $995,000 | 0.20% |
| DCF Advisers, LLC | 109,001 | $438,000 | 0.19% |
| Artal Group S.A. | 2,500,000 | $10,050,000 | 0.18% |
| Ikarian Capital, LLC | 1,124,872 | $4,522,000 | 0.15% |
| HighVista Strategies LLC | 40,920 | $164,000 | 0.12% |
| Tekla Capital Management LLC | 372,733 | $1,498,000 | 0.05% |